Drug Safety in Developing Countries

Prof. Yaser Mohammed Al-Worafi is a Professor of Clinical Pharmacy at the College of Pharmacy, University of Science and Technology of Fujairah, UAE (Previously known as Ajman University). He graduated with a bachelor's degree in Pharmacy (BPharm) from Sana’a University, Yemen and obtained a Master and PhD degree in Clinical Pharmacy from the Universiti Sains Malaysia (USM), Malaysia. He has more than 20 years experience in education, practice and research in Yemen, Saudi Arabia, United Arab Emirates and Malaysia. He has held various academic and professional positions including Deputy Dean for Medical Sciences College; PharmD program director, Head of Clinical Pharmacy/Pharmacy Practice department; Head of Teaching & learning committee, Head of Training Committee, head of the curriculum committee and other committees. He has authored over 100 peer-reviewed papers in international journals, and book chapters and edited more than 10 books by Elsevier, Springer, Taylors & Francis, USA. Prof.Yaser has supervised/co-supervised many PhD, Master, PharmD and B-Pharm students. He is a reviewer for eight recognized international peer-reviewed journals. Prof. Yaser prepared, designed, and wrote many pharmacy programs for many universities including Master of Clinical Pharmacy/Pharmacy Practice program; PharmD program and BPharm program; internship/clerkships for Master, PharmD and BPharm programs; more than 30 courses related to Clinical Pharmacy, Pharmacy Practice, Social Pharmacy and Patients care.

"This book offers a unique perspective on drug safety issues in developing countries and a comparison of different aspects including pharmacovigilance, medication errors, counterfeit medications, abuse, and storage and disposal. It highlights achievements and challenges for drug safety issues in over 21 countries and offers solutions to overcome these barriers. The significance of this book allows readers to understand how these drug safety challenges in developing countries can be improved to reduce adverse drug events to lower morbidity and mortality." --Doody Reviews

• Section 1 Drug safety-related issues1. Introduction: Why do we need a book on drug safety in developing countries?2. Medications safety-related terminology3. Medications registration and marketing: safety-related issues4. Pharmacovigilance5. Adverse drug reactions6. Medication errors7. Self-medication8. Antibiotics safety issue9. Drug-related problems10. Counterfeit and substandard medications11. Medication abuse and misuse12. Storage and disposal of medications13. Safety of medications in special population14. Herbal medicines safety issues15. Medications safety resources and tools16. Medications safety pharmacoeconomics-related issues17. Evidence-based medications safety practice18. Technology in medications safety19. Medications safety research issues20. Quality indicators for medications safetySection 2: Drug Safety in Asia21. Drug safety in Malaysia 22. Drug safety in Thailand23. Drug safety in Indonesia24. Drug safety in Pakistan25. Drug safety in India26. Drug safety in Nepal27. Drug safety in Sri Lanka28. Drug Safety in ChinaSection 3: Drug Safety in Middle East 29. Drug safety in Yemen30. Drug safety in Saudi Arabia31. Drug safety in UAE32. Drug safety in Jordan33. Drug safety in Lebanon34. Drug safety in Palestine35. Drug safety in QatarSection 4: Drug Safety in Africa36. Drug safety in Sudan37. Drug safety in Egypt38. Drug safety in Nigeria39. Drug safety in Mali40. Drug safety in Burkina FasoSection 5: Drug Safety in Latin America41. Drug safety in ChileSection 6: Comparisons and conclusions 42. Compare between the developing countries43. Drug Safety in Developing Versus Developed countries